Navigation Links
World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester

evel. The University's research grant income places it among the top 20 UK research universities. The University employs over 3,000 people, has an annual turnover of ??.5m, covers an estate of 94 hectares and is engaged in a ??m investment programme- among the biggest of any UK university.

Ather Mirza Director of Press and Publications University of Leicester University Road Leicester LE1 7RH tel: 0116 252 3335 email: pressoffice@le.ac.uk Looking for an expert? Try http://www.le.ac.uk/press/experts/intro.html UNIVERSITY OF LEICESTER - A member of the 1994 Group of universities that share a commitment to research excellence, high quality teaching and an outstanding student experience. * England's top ranked University for teaching quality and overall satisfaction amongst universities teaching full time students - National Student Survey 2005 and 2006 * One of just 19 UK universities to feature in world's top 200- Shanghai Jiao Tong International Index, 2005 and 2006. Ranked as a Top 20 university by The Times Good University Guide. * Short listed Higher Education Institution of the Year - THES awards 2005 and 2006 * Students' Union of the Year award 2005, short listed 2006 Founded in 1921, the University of Leicester has 19,000 students from 120 countries. Teaching in 18 subject areas has been graded Excellent by the Quality Assurance Agency- including 14 successive scores - a consistent run of success matched by just one other UK University. Leicester is world renowned for the invention of DNA Fingerprinting by Professor Sir Alec Jeffreys and houses Europe's biggest academic Space Research Centre. 90% of staff are actively engaged in high quality research and 13 subject areas have been awarded the highest rating of 5* and 5 for research quality, demonstrating excellence at an international level. The University's research gran
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
2. MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2 Clinical Data at the World Asthma Meeting
3. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
4. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
5. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
6. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
7. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
8. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
9. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
10. Two-Year Patient Registry Results Support Safety and Efficacy of Cypher Sirolimus-Eluting Coronary Stent in Real World Uses
11. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
Post Your Comments:
(Date:12/4/2009)... ,, PHILADELPHIA, Dec. 4 Teamster members employed ... are hard at work educating the public about the ... put Philadelphia,s blood supply at risk. More than ... picket line yesterday when their issues were ignored by ...
(Date:12/4/2009)... Corporation (Nasdaq: DYNT ) announced it has signed ... rehab supplies to Benchmark Physical Therapy with 65 clinics ... pleased to be named the sole-source supplier to Benchmark ... of sales and marketing at Dynatronics. "Benchmark is known ...
(Date:12/4/2009)... FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: ... medication delivery company, today announced the launch of its ... intravenous (I.V.) medications and solutions, and now offers a ... the award-winning, environmentally responsible VisIV product. The launch of ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 1The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 2The Healthcare Scoop Community Says 26apos 3BEye Care 26apos 3B 50306 3Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 1Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 2Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 3Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 1Air Methods Petitions NTSB for Reconsideration of Probable Cause Determination 50300 2
(Date:12/6/2009)... A new study by researchers from the Medical College ... hydroxyurea utilization for pain and other sickle cell disease ... part of both providers and patients were also identified. ... MS, assistant professor of pediatrics at the Medical College ... Wisconsin, will be presented at the American Society of ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...
(Date:12/6/2009)... 6, 2009 A new study provides welcome news ... venous thromboembolism (VTE). , The condition is estimated ... and occurs when an abnormal clot forms in a ... and swelling. In some cases, the clot may detach ... heart to the lungs, causing a potentially fatal condition ...
(Date:12/6/2009)... organizations and members of the community, in cooperation with the Greater ... a holiday party. This year,s attendance is expected to soar to ... , ... (PRWEB) December 6, 2009 -- Volunteer ... VA Healthcare System in West Los Angeles, will once again create ...
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2
... BETHESDA, Md., Feb. 3 The American College of Medical ... www.acmgfoundation.org . "The new ACMG Foundation website is not ... is but also to see first-hand how the initiatives of ... health through the translation of genetic discoveries into better patient ...
... the drug treatment of cancer pain in 2008 is valued ... released today by WWMR, Inc. The cancer pain market is ... the next decade. The increasing number of cancer pain ... the forecast period. Few of the many drugs in ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), ... Executive Officer, will present an update on the Company,s ... CEO & Investor Conference at 11:00 a.m. Eastern Time ... access the live audio broadcast or the subsequent archived ...
... , , TUESDAY, Feb. 3 (HealthDay News) -- Mammography use has ... to a new study from the U.S. Centers for Disease ... mammography use increased slightly from 2000 to 2006 in 17 ... fell by 0.3 to 5.3 percent in the 34 states ...
... 5%, study found , , TUESDAY, Feb. 3 (HealthDay News) -- ... of the deadly skin cancer melanoma later in life, a ... born in 1998 in Colorado, asking their parents about childhood ... were age 7 to look for nevi -- commonly known ...
... Volunteers play a critical role in world,s largest ... the coming months, hundreds of Rotary club members ... Korea, the United Kingdom and the Caribbean will ... volunteers and health workers to immunize children against ...
Other Medicine News:Health News:American College of Medical Genetics Foundation Unveils New Website: ACMG Foundation Supports Medical Genetics Research, Education and Practice 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 3Health News:Fewer Women Are Having Mammograms 2Health News:Childhood Beach Vacations May Boost Melanoma Risk 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: